Anemia predicts mortality in severe heart failure
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Objectives Our aim was to examine the relationships between serum hematocrit (Hct) and risk of all-cause mortality among patients with severe heart failure (HF).Background Anemia occurs with increased frequency in severe HF. However, few studies have examined the impact of anemia on mortality in this population.Methods Using a prospective cohort design, we evaluated the relationships between baseline serum Hct and mortality among 1,130 patients with left ventricular EF <30% and New York Heart Association functional class IIIB or IV HF treated with angiotensin-converting enzyme inhibitors, diuretics, and digitalis. Mortality was ascertained by centralized adjudication.Results The mean Hct was 41.8% (range 25.4% to 58.8%). Over 15 months of mean follow-up, there were 407 deaths (29 per 100 person-years). After adjustment for potential confounders, those in the lowest quintile of Hct (range 25.4% to 37.5%) had a 52% higher risk of death (hazard ratio 1.52, 95% confidence interval 1.11 to 2.10), compared with the highest quintile (range 46.1% to 58.8%). Within the lowest quintile of Hct, each 1% decrease in Hct was associated with an 11% higher risk of death (p < 0.01), whereas within the four higher quintiles of Hct, Hct was not associated with total mortality. Evaluation of different causes of death indicated that a lower Hct was strongly associated with death from progressive HF, rather than sudden death or other deaths.Conclusions Among patients with severe HF, anemia is a significant independent risk factor for death, with a progressively higher risk with increasing severity of anemia. Further investigation of the etiologies, prevention, and treatment of anemia in severe HF is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The importance of anemia for CHF is underscored by a linear increase of mortality with declining Hb levels [19–21].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [20]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“Anaemia is a common occurrence (and risk factor) in heart failure [727-729], again implying a role for dysregulated iron metabolism”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure
Packer, M., O'Connor, C. M., Ghali, J. K., Pressler, M. L., Carson, P. E., Belkin, R. N., Miller, A. B., Neuberg, G. W., Frid, D., Wertheimer, J. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610103351504 · Cited by 1,196
Blood Transfusion in Elderly Patients with Acute Myocardial Infarction
Wu, W.-C., Rathore, S. S., Wang, Y., Radford, M. J., & Krumholz, H. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010615 · Cited by 952
Endotoxin and immune activation in chronic heart failure: a prospective cohort study
Niebauer, J., Volk, H.-D., Kemp, M., Dominguez, M., Schumann, R. R., Rauchhaus, M., Poole-Wilson, P. A., Coats, A. J., & Anker, S. D. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09286-1 · Cited by 877
The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease
Foley, R. N., Parfrey, P. S., Harnett, J. D., Kent, G. M., Murray, D. C., & Barre, P. E. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90130-4 · Cited by 769
Silverberg, D. S., Wexler, D., Blum, M., Keren, G., Sheps, D., Leibovitch, E., Brosh, D., Laniado, S., Schwartz, D., Yachnin, T., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00613-6 · Cited by 728 · cited 1×
“Additionally, clinical studies among small numbers of HF patients (n 26 [10] and n 32 [11]) indicate that treatment of anemia with erythropoietin and iron improves symptoms and the ejection fraction (EF) and decreases hospitalizations and the need for diuretics, suggesting that anemia may be a modifiable risk factor i…”
BackgroundHorwich, T. B., Fonarow, G. C., Hamilton, M. A., MacLellan, W. R., & Borenstein, J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01854-5 · Cited by 712
Al-Ahmad, A., Rand, W. M., Manjunath, G., Konstam, M. A., Salem, D. N., Levey, A. S., & Sarnak, M. J. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01470-x · Cited by 701
Silverberg, D. S., Wexler, D., Sheps, D., Blum, M., Keren, G., Baruch, R., Schwartz, D., Yachnin, T., Steinbruch, S., Shapira, I., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01248-7 · Cited by 644 · cited 1×
“Additionally, clinical studies among small numbers of HF patients (n 26 [10] and n 32 [11]) indicate that treatment of anemia with erythropoietin and iron improves symptoms and the ejection fraction (EF) and decreases hospitalizations and the need for diuretics, suggesting that anemia may be a modifiable risk factor i…”
BackgroundMcClellan, W. M., Flanders, W. D., Langston, R. D., Jurkovitz, C., & Presley, R. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000018409.45834.fa · Cited by 465
Pathophysiology of anaemia: focus on the heart and blood vessels
Metivier, F., Marchais, S. J., Guerin, A. P., Pannier, B., & London, G. M. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/oxfordjournals.ndt.a027970 · Cited by 370
Cited by
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Self-citationAdvances in metal-induced oxidative stress and human disease
Jomova, K., & Valko, M. (2011) · Toxicology · doi:10.1016/j.tox.2011.03.001 · Cited by 3,207
“Anemia is a potential risk factor and has been associated with heart failure (Mozaffarian et al., 2003; Bolger et al., 2006), pointing to a role for dysregulation of iron metabolism.”
BackgroundYancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8776 · Cited by 2,106
Self-citationThe Seattle Heart Failure Model: Prediction of Survival in Heart Failure
Levy, W. C., Mozaffarian, D., Linker, D. T., Sutradhar, S. C., Anker, S. D., Cropp, A. B., Anand, I., Maggioni, A., Burton, P., Sullivan, M. D., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.584102 · Cited by 2,021
Self-citationAnemia and Mortality in Heart Failure Patients
Groenveld, H. F., Januzzi, J. L., Damman, K., van Wijngaarden, J., Hillege, H. L., van Veldhuisen, D. J., & van der Meer, P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.061 · Cited by 764
Metadata
- Authors
- Mozaffarian, D., Nye, R., & Levy, W. C.
- Affiliations
- University of Washington (US)
- Pfizer (United States) (US)
- Corresponding author
- Mozaffarian, Dariush
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2003-06
- Volume
- 41
- Issue
- 11
- Pages
- 1933-1939
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W17798182
- Cited by
- 294
- References
- 25
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 3 · 2023: 5 · 2022: 5 · 2021: 7 · 2020: 8 · 2019: 7 · 2018: 3 · 2017: 7 · 2016: 6 · 2015: 9 · 2014: 11 · 2013: 13 · 2012: 6
- FWCI
- 19.76
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3698 d)
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- anemia, severe heart failure, all-cause mortality, left ventricular ejection fraction, mortality risk factors, ACE inhibitors, diuretics, digitalis
- MeSH terms
- Aged, Anemia, Calcium Channel Blockers, Cause of Death, Female, Follow-Up Studies, Heart Failure, Hematocrit, Humans, Male, Middle Aged, Predictive Value of Tests, Prospective Studies, Risk Factors, Severity of Illness Index, Sex Factors, Stroke Volume, Cohort Studies, Survival Analysis, Treatment Outcome, Amlodipine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anemia predicts mortality in severe heart failure. https://app.cochat.ai/papers/10.1016/s0735-1097(03)00425-x
- The paper
- Mozaffarian, D., Nye, R., & Levy, W. C. (2003). Anemia predicts mortality in severe heart failure. Journal of the American College of Cardiology. https://doi.org/10.1016/s0735-1097(03)00425-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.